AzTrials
AzTrials

Adverse EffectsNCT02162147

How Safe Are Our Pediatric Emergency Departments?

An observational study of Adverse Effects and Adverse Drug Event, run by Children's Hospital of Eastern Ontario at 10 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patient safety is an internationally recognized health care priority. Canadian data suggests that about 8% of adults admitted to hospital experience unintended harm (or 'adverse events') from the health care provided during their hospital stay. Read more about this study

Who is it for?
Ages 1 day to 18 years
Conditions the study is for
Adverse Effects, Adverse Drug Event
How many people
6,385 participants
Where
10 sitesCanada
Study dates
Nov 2014to Mar 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Subjects presenting to one the nine participating Canadian pediatric hospitals (BC Children's Hospital (BC), CHU Sainte-Justine (PQ), Children's Hospital of Eastern Ontario (ON), The Hospital for Sick Children (ON), Children's Hospital of Western Ontario (ON), Children's Hospital of Winnipeg (MB), Janeway Children's Health and Rehabilitation Centre (NL), Stollery Children's Hospital (AB) and Alberta Children's Hospital (AB)) Emergency Departments

Who may be able to join

  • Age less than 18 years
  • Patients from all pediatric Canadian Triage Acuity Scale categories (pedsCTAS; 1:resuscitation; 2:emergent, 3:urgent, 4:semi-urgent, 5:non-urgent).

Who cannot join

  • Insurmountable language barrier that prevents informed consent and follow-up by telephone.
  • Children and families that will be unavailable for telephone follow-up in the three weeks after their emergency department visit (e.g., no telephone in the home, travelling out of the country, etc.).

Trial locations and contacts

10 sites in 1 country.

10 sites in 1 country

Canada10 sites
  • Alberta Children's Hospital

    Calgary, Alberta

  • Stollery Children's Hospital

    Edmonton, Alberta

  • Children's Hospital at London Health Sciences Centre

    London, Ontario

  • CHU Sainte-Justine

    Montreal, Quebec

  • Children's Hospital for Eastern Ontario

    Ottawa, Ontario

  • Janeway Children's Health and Rehabilitation Centre

    St. John's, Newfoundland and Labrador

  • The Hospital for Sick Children

    Toronto, Ontario

  • BC Children's Hospital

    Vancouver, British Columbia

  • Manitoba Institute of Child Health

    Winnipeg, Manitoba

  • Winnipeg Children's Hospital

    Winnipeg, Manitoba

Other trials in Canada

About this study

Official title: How Safe Are Our Pediatric Emergency Departments? A National Prospective Cohort Study

Patient safety is an internationally recognized health care priority. Canadian data suggests that about 8% of adults admitted to hospital experience unintended harm (or 'adverse events') from the health care provided during their hospital stay. On a national level, this represents almost 25,000 preventable deaths among hospitalized adults each year. The emergency department is recognized as a high-risk environment for adverse events but most patient safety research is not specific to the emergency department. As well, the vast majority of people treated in the emergency department are sent home after their visit; yet safety research focuses primarily on people who are admitted to hospital. Finally, although children have also been identified as particularly high risk for suffering adverse events, very little research has been done on how often these events occur among children who visit the emergency department. Our study will address this gap in our knowledge about patient safety and provide important information on the frequency, severity and preventability of adverse events occurring among children in the emergency department. This information will help us to improve the safety of emergency department care for all Canadian children.

Keywords
patient safety, pediatrics, emergency medicine
Medical subject headings
Drug-Related Side Effects and Adverse Reactions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients who experience an adverse event related to emergency department care within 3 weeks of an emergency department visit

    An adverse event will be defined as an event that results in unintended harm to the patient, and is related to the health care and/or services provided to the patient rather than to the patient's underlying medical condition. Emergency department care will be defined as any care provided in the emergency department and will explicitly include care provided by emergency department specific staff (i.e., staff physicians, nurses, and allied health care providers) and care provided by consultants in the emergency department.

    Measured: 3 weeks

Secondary outcomes (8)
  1. Proportion of patients experiencing a preventable adverse event

    Measured: 3 weeks

  2. Clinical severity of adverse events

    For all patients, we will report the clinical severity as: (a) an abnormality on laboratory testing, (b) ≤1 day of symptoms, (c) >1 day of symptoms, (d) nonpermanent disability (e) permanent disability, or (f) death. For admitted patients, we will also report clinical severity according to The Institute for Health Care Improvement trigger tool categories: (a) temporary harm to the patient requiring intervention, (b) temporary harm to the patient requiring initial or prolonged hospitalization, (c) permanent patient harm, (d) intervention required to sustain life, or (e) death.

    Measured: 3 weeks

  3. Types of adverse events

    Adverse Events will be classified as (a) diagnostic issue, (b) management issue, (c) unsafe disposition decision, (d) suboptimal follow-up, (e) medication adverse effect, (f) procedural complication, and (g) nosocomial infection

    Measured: 3 weeks

  4. System response required for adverse events

    The response will be classified as: (a) no treatment (symptoms only), (b) required medical/surgical intervention, (c) visit to MD office, (d) Emergency Department visit, (e) admission to hospital. These previously published broad categories were chosen in order to address the effect of the Adverse Events at both the patient and health care system level.These categories are not exclusive.

    Measured: 3 weeks

  5. Proportion of patients for whom an adverse event is related to emergency department specific care

    Versus consulting specialty service care provided in the emergency department or care provided after the child's emergency department visit

    Measured: 3 weeks

  6. Adverse events related to care provided in the emergency department by consulting service

    Measured: 3 weeks

  7. Patient and system level characteristics associated with adverse events and preventable adverse events

    Measured: 3 weeks

  8. Adverse events that occur within the 3-week time frame but are not related to care received in the emergency department

    Including those related to in-hospital care and primary care

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionNov 2015
  4. Study completionMar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
6,385 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02162147
Sponsor's protocol ID
14/70X
Other IDs
312463
Status last verified
Jan 2018
First submitted
10 Jun 2014
Last updated
17 Jan 2018
Results posted
No
Data monitoring committee
No

Publications

  • Plint AC, Newton A, Stang A, Bhatt M, Barrowman N, Calder L; Pediatric Emergency Research Canada (PERC). How safe are our paediatric emergency departments? Protocol for a national prospective cohort study. BMJ Open. 2014 Dec 4;4(12):e007064. doi: 10.1136/bmjopen-2014-007064.

    PubMed 25475246

Questions about this trial

What is this clinical trial studying?

An observational study of Adverse Effects and Adverse Drug Event, run by Children's Hospital of Eastern Ontario at 10 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients who experience an adverse event related to emergency department care within 3 weeks of an emergency department visit (time frame: 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02162147, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in